Orbimed Advisors - DERMIRA INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of DERMIRA INC
ValueSharesWeighting
Q4 2019$3,790,000
-48.9%
250,000
-75.8%
0.05%
-60.6%
Q4 2018$7,417,000
-34.0%
1,031,5960.0%0.14%
+1.5%
Q3 2018$11,244,000
+18.5%
1,031,5960.0%0.14%
+19.5%
Q2 2018$9,491,000
-71.1%
1,031,596
-12.7%
0.11%
-72.8%
Q4 2017$32,848,000
-14.3%
1,181,168
-16.8%
0.42%
+13.4%
Q3 2017$38,310,000
-7.3%
1,418,8730.0%0.37%
-15.5%
Q2 2017$41,346,000
+18.4%
1,418,873
+38.6%
0.43%
+9.3%
Q1 2017$34,917,000
+170.5%
1,023,673
+140.5%
0.40%
+141.5%
Q4 2016$12,908,000
-10.3%
425,6000.0%0.16%0.0%
Q3 2016$14,394,000425,6000.16%
Other shareholders
DERMIRA INC shareholders Q3 2023
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 2,528,311$38,329,0007.20%
Telemetry Investments, L.L.C. 135,559$2,055,0006.85%
GREAT POINT PARTNERS LLC 2,621,333$39,739,0003.46%
Trellus Management Company, LLC 120,421$1,826,0003.06%
Asymmetry Capital Management, L.P. 81,127$1,442,0002.58%
NEA Management Company, LLC 3,506,649$53,161,0002.51%
Soleus Capital Management, L.P. 164,600$2,495,0002.41%
Partner Investment Management, L.P. 16,892$256,0001.84%
Broadfin Capital, LLC 896,334$13,588,0001.82%
PFM Health Sciences, LP 2,271,180$34,431,0001.64%
View complete list of DERMIRA INC shareholders